Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The sooner you learn that OTC companies could care less about retail the less rage you will have.
They need money and they are sick of dealing with the OTC crowd. They want to be uplisted to draw institutional investors that can’t buy the pinks. Why would they have informed investors without the intent to follow through?
You are wrong. I do not want to see a reverse split of the stock. But it will happen. I don’t know when bit it will happen. My preference would be at a much higher price. Are we clear champ? Stop putting words in my mouth.
They did a reverse split dude, 200:1. They had 1.4 BILlION shares prior to the RS, more than double what CUBT has now. You’re not comparing apples to apples as usual. A reverse split is coming here, whether you like it or not. Get used to the idea.
“Well it’s good” is not evidence. The other day you were criticizing someone for not having evidence to support a belief but here you are doing the same. You said insiders were selling yesterday. Where is the evidence? You make assumptions all the time without actual evidence yet criticize others for the same.
What a the evidence of that comment?
I can do math dude. You do not read responses it appears. I am not a fan of a RS split. Good day mate.
You do realize the share price goes up when there is a reverse split. Based on your posts it does not appear that you understand the concept of a reverse split. You should study up on the topic.
A RS can be a good thing if it gets you to a higher exchange where they can attract institutional investors. It also creates a very thin float, so any news can send it. They need money to advance their four solutions. What would you do?
I didn’t say it was good. I think it is inevitable. People can whine all they want. It is not going to change the course of action the company takes. Am I excited about a RS at .05. Of course not. It is not up to us retail investors however.
Dilution is adding shares to the number of shares outstanding. A RS will typically accompany a corresponding increase in price to maintain the same capitalized value pre and post split. A stock split does not dilute the ownership interests of existing shareholders.
As far as where the company is at, they are going to need money to advance their 4 drug solutions. How would you expect them to raise capital if not through some institutional investment that will include share ownership? It’s going to happen. If you do not like that prospect I would recommend selling. They need the capital to advance their business. This is very common on all exchanges.
I am basing my estimates on the company’s two year time horizon to bring drug solutions to some kind of monetization event, which is their stated business model. If I recall I believe they gained the worldwide rights to repurpose Metformin into an eye drop in February 2021. The two year time frame would be February 2023. So I backed into the dates. It seems clear to me the delay in the IND had a lot to do with the timing of securing the CRADA in addition to whatever supply issues the company had because of COVID last year.
With the CRADA announcement and Dr. Chew leading the trials, I think discussions with big pharma may begin soon. At least preliminary. AMD is such a large market and growing with an aging population. I am thinking human trials will be underway after animal studies conclude in a few months. Human trials will probably take 90 days. By the end of the year they could have a suitor interested. How long a deal takes will be contingent on the trials and terms. The CRADA agreement was a big step.
You are right. No volume and no new buyers. Hopefully the market will catch up to the news.
You are right. Dr. Chew is one of, if not the most renowned, researchers in her segment of eye care in the world. Absolute beast. For her to want to take this on speaks volumes. A Doctor of her caliber does not ask to be the Lead Investigator if for this CRADA if there is not huge potential here. By the end of 2022 big pharma will be knocking. I am willing to be as patient as needed.
Plenty? Which ones? I am really curious.
There never is any evidence about insider selling of CUBT shares. Speculation, yes, driven by conspiracy theories; evidence, none. Why would insiders be selling on news they just entered into a collaborative CRADA with the NATIONAL EYE INSTITUTE to move their Metformin eye drop solution forward. Their work just took a major step forward.
People should actually research “this cradd research thing.” LOL. Ignorance is not bliss when it comes to the CUBT CRADA.
This CRADA will get big pharma’s attention. Up to this point it has been all speculation about a relationship with the NEI. The product CUBT is collaborating on with the National Eye Institute is a Metformin eye drop solution, when the main treatment up to this point has been an actual injection in the eye. How big of a market is there for an eye drop, utilizing one of the safest and most prescribed drugs in the world (used to treat diabetes) to be repurposed to replace an injection? Large! This is a $10B industry. And now they have a formal collab. with the National Eye Institute. The market will figure it out. In the meantime good buy op. imo.
The market will wake up eventually. This is a huge step. This news creates a great buy opportunity at this price level imo. People have no idea of the process and work needed to secure a Collaborative Research and Development Agreement with the National Institute of Health’s National Eye Institute.
This is big news. The NEI is the gold standard for all things eye research. For the NEI to agree to do a CRADA with CUBT for Metformin is MASSIVE! Do your homework on this. The NEI has to believe in your product to agree to this.
And who are those people? Pretty strong g accusations. If you don’t have specifics, it is all speculation.
In May of 2021 they had the license for about three months at that time. Things take time. I am patient. They will get it done.
Or maybe not.
The company announced the grant of exclusive worldwide license from the National Institute of Health for repurposing Metformin to treat degenerative eye disease on February 4, 2021. Dr. Kapil Bharti from the National Eye Institute was added to CUBT’s Advisory Board on April 29, 2021. Dr Bharti has been involved in the development of the Metformin eye drop solution.
The company’s goal is to bring their solutions to a monetization event within a two year time frame. It has been just over one year since they were awarded the worldwide license and less than one year since Dr. Bharti joined the board. Give this management team time. They know what they are doing imo. And they are on track despite the delay in filing the IND. It is a rigorous process they are going through.
CUBT the comeback kid. What a recovery. Guess those bad loan terms were so bad after all. Most people see the potential with what the company owns. Only regret is not adding yesterday.
Indeed. Shares were stolen at great prices yesterday. People need to know what they own.
Apparently the market doesn’t care too much about the terms. The stock price is exactly where it was when I added last week. It sounds like to me you place zero value on the worldwide license CUBT has to a Metformin eye drop treatment for AMD, the initiative of which is being lead by Dr. Bharti who works at the National Eye Institute (part of the National Health Institute) and is an Advisor to CUBT management on its development. I am thinking more people are more intrigued by this potential than the terms of a short term loan to fund their research which is needed to advance to the product stage eventually.
You may not have been stealing shares. Some people took full advantage of the over reaction to the news and got some really cheap shares. I call that stealing shares based on fear mongering tactics of some. Seen this way too many times before big moves north which I am fully expecting here.
It should bother me? Who is anyone to tell me what should or should not bother me? If it bothers you fine. If this becomes a $10 stock praise the good Lord is what I would say because I would have made $$. I really don’t care what other people make. If you do then so be it. Just don’t project your values on me and tell me what should bother me. Not your place.
Buy when there is blood in the water. I will be at EOD. Don’t let anyone steal your shares. It is a $1M bridge loan like others have said to keep. Money needed to keep things moving forward.
To make a comment that The not exist in a year is one of the most ridiculous comments made to date on this board. If not ridiculous then certainly one made on wild speculation about lawsuits. It is laughable.
CUBT will not be late on the 10K. Lots of lazy people shoot from the hip and make comments based on emotion and not facts. Google is a really good tool to answer questions such as when 10K’s are due.
The report is not late. Don’t spew lies.
I just take it as it comes. I saw that .0598 ask and liked the price and bought. Hopefully news hits sooner than later. We shall see. Was glad to pick up whatever amount I could at that ask price.
Added some here at .0598. Only filled 17K of 50K order. If you want any volume here you won’t get many at these prices.
“The research was done by the National Eye Institute, which is part of the National Institutes of Health.”
Like reading this in the article. Same federal agency that CUBT will soon be partnering with on their Metformin eye drop research.
Personally I could care less what people on this board think about anything. We are all responsible for our own decisions. I am in this because I believe in where they are going and the value of the licenses they hold. What people were saying two weeks ago, two months ago or last year is immaterial to me. I know what I own and am being patient on their execution. It took me two years to get a tax refund back from the federal government. Entering into a relationship with the NEI, which I believe the company is close to accomplishing, takes time. Lots of red tape and hoops to jump through. With that said I can certainly understand one’s frustration and impatience. For me I ain’t too worried about the delay in news. It will come when ready.
I’ve been receiving a lot of friend requests and follows from Huntpost subs. The upside on this social site is enormous.
All good. I am sure one of many things we have in common is that we are both long WDLF. GLTA who are long.